|
|
| March 30, 2008: Dr. Peter Kowey Discusses the Efficacy and Safety of Vernakalant Hydrochloride Injection post-CABG |
Dr. Peter Kowey presents: Efficacy and Safety of Vernakalant Hydrochloride Injection for
the Treatment of Atrial Fibrillation After Valvular or Coronary Artery Bypass Surgery, at
the SCAI-ACC i2.08 Summit in Chicago.
Peter Kowey, MD
Honoraria from and consultant, advisory board member, and speaker’s bureau member for
Cardiome Pharma Corp. and Astellas Pharma US, Inc.
Denis Roy, MD
Honoraria from and consultant for Astellas Pharma US, Inc. Consultant and advisory board
member for and ownership interest in Cardiome Pharma Corp.
Craig Pratt, MD
Consultant and advisory board member for Cardiome Pharma Corp. and Astellas Pharma US,
Inc. Speaker’s bureau member for Cardiome Pharma Corp.
Peter J. Schwartz, MD
None
Paul Dorian, MD
Honoraria from Cardiome Pharma Corp. and Astellas Pharma US, Inc. Research grant received
from and consultant and advisory board member for Cardiome Pharma Corp.
L. Brent Mitchell, MD
Honoraria and research grant received from, ownership interest in, and consultant,
advisory board member, and speaker’s bureau member for Cardiome Pharma Corp.
Egon Toft, MD
None
Sponsorship for interviews at SCAI-ACC 2008 was provided by the Center for Health
Education (CHE) through unrestricted joint educational grants from Scios, Astellas and
Daiichi/Lilly.
[ Download video ] |
|
No comments have been submitted
|